UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical efficacy of new JAK inhibitors under development. Just more of the same?

Rheumatology (Oxford, England), 2019-02, Vol.58 (Supplement_1), p.i27-i33

Westhovens, Rene

2019

Volltextzugriff (PDF)

Safety and Efficacy of Filgotinib: Up to 4-year Results From an Open-label Extension Study of Phase II Rheumatoid Arthritis Programs

Journal of rheumatology, 2021-08, Vol.48 (8), p.1230-1238

2021

Volltextzugriff (PDF)

Effect of filgotinib, a selective JAK 1 inhibitor, with and without methotrexate in patients with rheumatoid arthritis: patient-reported outcomes

Arthritis research & therapy, 2018-03, Vol.20 (1), p.57-57, Article 57

2018

Volltextzugriff (PDF)

Physical activity assessment in patients with axial spondyloarthritis compared to healthy controls: a technology-based approach

PloS one, 2014-02, Vol.9 (2), p.e85309-e85309

2014

Volltextzugriff (PDF)

Lessons from negative phase 3 trials in rheumatoid arthritis anno 2023

Annals of the rheumatic diseases, 2023-12, Vol.82 (12), p.1503-1505

2023

Volltextzugriff (PDF)

Managing inadequate response to initial anti-TNF therapy in rheumatoid arthritis: optimising treatment outcomes

Therapeutic Advances in Musculoskeletal Disease, 2022, Vol.14, p.1759720X221114101-1759720X221114101

2022

Volltextzugriff (PDF)

Filgotinib in rheumatoid arthritis

Expert review of clinical immunology, 2023-02, Vol.19 (2), p.135-144

Westhovens, Rene

2023

Volltextzugriff (PDF)

Individuals with ACPA-negative clinically suspect arthralgia experience more symptom burden: is seronegative disease truly less severe?

Rheumatology (Oxford, England), 2024-09, Vol.63 (9), p.2323-2324

2024

Volltextzugriff (PDF)

Non-specific symptoms and post-treatment Lyme disease syndrome in patients with Lyme borreliosis: a prospective cohort study in Belgium (2016–2020)

BMC infectious diseases, 2022-09, Vol.22 (1), p.1-756, Article 756

2022

Volltextzugriff (PDF)

CT-P13 SC for the treatment of rheumatoid arthritis

Expert review of clinical immunology, 2022-01, Vol.18 (1), p.5-13

Westhovens, Rene

2022

Volltextzugriff (PDF)

Innovative approaches to biologic development on the trail of CT-P13: biosimilars, value-added medicines, and biobetters

mAbs, 2021-01, Vol.13 (1), p.1868078

2021

Volltextzugriff (PDF)

Prospective Study to Assess Short-Term Intra-Articular and Tenosynovial Changes in the Aromatase Inhibitor–Associated Arthralgia Syndrome

Journal of clinical oncology, 2008-07, Vol.26 (19), p.3147-3152

2008

Volltextzugriff (PDF)

Pericarditis as a manifestation of IgG4-related disease

Rheumatology international, 2022-07, Vol.42 (7), p.1287-1295

2022

Volltextzugriff (PDF)

Potential target for treating osteoporosis

International journal of clinical rheumatology, 2022-07

Westhovens, Rene

2022

Volltextzugriff (PDF)

Calibration and Validation of the Dutch-Flemish PROMIS Pain Interference Item Bank in Patients with Chronic Pain

PloS one, 2015-07, Vol.10 (7), p.e0134094

2015

Volltextzugriff (PDF)

Safety and efficacy of the selective costimulation modulator abatacept in patients with rheumatoid arthritis receiving background methotrexate: a 5-year extended phase IIB study

Journal of rheumatology, 2009-04, Vol.36 (4), p.736-742

2009

Volltextzugriff (PDF)

Accelerometry-Based Activity Recognition and Assessment in Rheumatic and Musculoskeletal Diseases

Sensors (Basel, Switzerland), 2016-12, Vol.16 (12), p.2151-2151

2016

Volltextzugriff (PDF)

Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis

Arthritis research & therapy, 2021-10, Vol.23 (1), p.269-11, Article 269

2021

Volltextzugriff (PDF)

Widespread pain in axial spondyloarthritis: clinical importance and gender differences

Arthritis research & therapy, 2018-07, Vol.20 (1), p.156-156, Article 156

2018

Volltextzugriff (PDF)

Longitudinal trajectories of fatigue in early RA: the role of inflammation, perceived disease impact and early treatment response

Annals of the rheumatic diseases, 2022-10, Vol.81 (10), p.1385-1391

2022

Volltextzugriff (PDF)

Antinuclear antibody as entry criterion for classification of systemic lupus erythematosus: pitfalls and opportunities

Annals of the rheumatic diseases, 2019-08, Vol.78 (8), p.e76-e76

2019

Volltextzugriff (PDF)

Viewpoint: Supporting mental health in the current management of rheumatoid arthritis: time to act

Rheumatology (Oxford, England), 2023-10, Vol.62 (SI3), p.SI274-SI281

2023

Volltextzugriff (PDF)

Psychosocial Burden Predicts Sustained Remission in Early Rheumatoid Arthritis: Unraveling the Complex Interplay of Well‐Being and Disease Activity

Arthritis care & research (2010), 2023-04, Vol.75 (4), p.758-767

2023

Volltextzugriff (PDF)

Technical and Diagnostic Performance of 6 Assays for the Measurement of Citrullinated Protein/Peptide Antibodies in the Diagnosis of Rheumatoid Arthritis

Clinical chemistry (Baltimore, Md.), 2007-03, Vol.53 (3), p.498-504

2007

Volltextzugriff (PDF)

1 – 25 von 332

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(312)
Mit Volltextzugriff
(255)

Publikationsform

Sprache

Englisch
(330)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(264)
Life Sciences & Biomedicine
(256)
Rheumatology
(208)
Humans
(207)
Female
(134)
Male
(128)
Rheumatoid Arthritis
(114)
Middle Aged
(109)
Adult
(102)
Arthritis, Rheumatoid - Drug Therapy
(83)
Treatment Outcome
(68)
Aged
(63)
Biological And Medical Sciences
(62)
Medical Sciences
(58)
Antirheumatic Agents - Therapeutic Use
(57)
Patients
(52)
Arthritis
(46)
Drug Therapy, Combination
(44)
Severity Of Illness Index
(44)
Diseases Of The Osteoarticular System
(41)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Clinical efficacy of new JAK inhibitors under development. Just more of the same?

Safety and Efficacy of Filgotinib: Up to 4-year Results From an Open-label Extension Study of Phase II Rheumatoid Arthritis Programs

Effect of filgotinib, a selective JAK 1 inhibitor, with and without methotrexate in patients with rheumatoid arthritis: patient-reported outcomes

Physical activity assessment in patients with axial spondyloarthritis compared to healthy controls: a technology-based approach

Lessons from negative phase 3 trials in rheumatoid arthritis anno 2023

Managing inadequate response to initial anti-TNF therapy in rheumatoid arthritis: optimising treatment outcomes

Filgotinib in rheumatoid arthritis

Efficacy and safety of filgotinib alone and in combination with methotrexate in Japanese patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 3)

Individuals with ACPA-negative clinically suspect arthralgia experience more symptom burden: is seronegative disease truly less severe?

Non-specific symptoms and post-treatment Lyme disease syndrome in patients with Lyme borreliosis: a prospective cohort study in Belgium (2016–2020)

CT-P13 SC for the treatment of rheumatoid arthritis

Innovative approaches to biologic development on the trail of CT-P13: biosimilars, value-added medicines, and biobetters

Prospective Study to Assess Short-Term Intra-Articular and Tenosynovial Changes in the Aromatase Inhibitor–Associated Arthralgia Syndrome

Pericarditis as a manifestation of IgG4-related disease

Potential target for treating osteoporosis

Calibration and Validation of the Dutch-Flemish PROMIS Pain Interference Item Bank in Patients with Chronic Pain

Safety and efficacy of the selective costimulation modulator abatacept in patients with rheumatoid arthritis receiving background methotrexate: a 5-year extended phase IIB study

Accelerometry-Based Activity Recognition and Assessment in Rheumatic and Musculoskeletal Diseases

Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis

Widespread pain in axial spondyloarthritis: clinical importance and gender differences

Longitudinal trajectories of fatigue in early RA: the role of inflammation, perceived disease impact and early treatment response

Antinuclear antibody as entry criterion for classification of systemic lupus erythematosus: pitfalls and opportunities

Viewpoint: Supporting mental health in the current management of rheumatoid arthritis: time to act

Psychosocial Burden Predicts Sustained Remission in Early Rheumatoid Arthritis: Unraveling the Complex Interplay of Well‐Being and Disease Activity

Technical and Diagnostic Performance of 6 Assays for the Measurement of Citrullinated Protein/Peptide Antibodies in the Diagnosis of Rheumatoid Arthritis

Suchergebnisse filtern